Sequence logos of (a) hTAS2Rs and (b) hORs, based on the multiple sequence alignments (MSAs) of each human chemosensory receptor subfamily. The first N-terminal residues (28 for hTAS2Rs and 32 for hORs) have been omitted for the sake of clarity; the same was done for the last C-terminal positions (9 and 101, respectively). These segments are well outside the seven transmembrane bundle of GPCRs. The full-length MSAs can be obtained from the authors upon request.
(a) (b) Section 1.3: Target-template pairwise alignments. The HMM-based pairwise alignment between each of the hChem-GPCRs studied in this work and the template (β2-adrenoceptor, PDB code 4LDE) are provided below in PIR format. (Colquhoun, 1998; Strange, 2008) . However, any mutation may simultaneously shift the relative population of the spectrum of receptor conformations relative to the wild-type receptor (Changeux and Edelstein, 2011) . This leads to conformation-dependent effects, rather than agonist-based effects (Kenakin, 2002) . In addition, effects indirectly related to the ligand affinity of the receptor are also possible, such as shaping of the binding cavity (Marchiori et al., 2013; Sandal et al., 2015) and second-shell effects (i.e. residues important to maintain the actual binding residue(s) in the right conformation to interact with the ligand) (Singh et al., 2011 , Geithe et al., 2017 . As a result, EC 50 measurements cannot be simply interpreted in terms of binding affinity or activation (Colquhoun, 1998; Strange, 2008; Williams and Hill, 2009; Strange, 2010) .
Section 2.2: Statistical analysis of the docking results.
Supplementary Table 1 . Analysis of the docking data of the hChem-GPCR/agonist complexes predicted by Haddock (Dominguez et al., 2003) , Autodock Vina (Trott and Olson, 2010) and Glide (Friesner et al., 2004) . In the first column all the hChemGPCR/agonist pairs for which experimental data are available are indicated; the charge of the ligand is shown in parentheses. The second column shows the residues for which mutagenesis data are available. Residues belonging to the bottom half of the receptor, to the N-or C-termini, and to the TM8 have been omitted, as they are well outside the canonical orthosteric binding site of class A GPCRs (Venkatakrishnan et al., 2013) and thus they are expected not to be involved in ligand binding. In the third column, residues are numbered accordingly to the GPCRdb numbering scheme (Isberg et al., 2015) of our template, the β2 adrenoceptor (PDB code: 4LDE). In the fourth column, interpretation of EC 50 values for the corresponding residues is reported using the following nomenclature: c = change in EC 50 ; nc = no significant change in EC 50 . In the following columns, for each docking program it is indicated whether the residue is within the 5.5 Å cut-off distance from the ligand (Y=yes; N=no) and the prediction outcome for this residue (TP=true positive, TN=true negative, FP=false positive, FN=false negative, see Figure 3 in the main text), depending on the presence or absence of an actual chemical interaction. For each hChemGPCR/agonist complex, the resulting recall and precision values are shown in the last row (in red for HADDOCK, green for AutoDock Vina and blue for Glide). 
